Looks like IM phase III test has been successful Zhongyu Trogarzo intramuscular injection phase III data is expected to be released in April
Response(0) Popularity( 74 ) Favorite(0)2023/03/21 10:44
MoneyDJ News 2023-03-21 10:44:18 Reported by reporter Xiao Yanxiang
Zhongyu (4147), a new drug research and development company, used Trogarzo intramuscular injection for the post-AIDS treatment. Phase III clinical trials have been completed. According to market estimates, the data is expected to be released in April. The new core product TMB365/380, which has attracted more attention from the outside world, has completed the three-dose safety test of the Pioneer Group, and the data will be released in late June at the earliest.
In addition to the initial intravenous injection dosage form, Zhongyu's existing drug Trogarzo has gradually added intravenous injection and intramuscular injection dosage forms. Among them, the intravenous injection dosage form has obtained the US drug certification last year and is expected to be launched in the second quarter of this year. In addition, the phase III clinical trial of the intramuscular injection dosage form is in the final data collection stage, and the successful data will be released in April, and the application for drug certificate will be submitted in the second quarter, and the certificate will be obtained in the first quarter of next year.
In addition, TMB356/380, which is used for the long-term maintenance therapy of first-line AIDS patients, is currently in Phase 1b/2 stage. The three groups of pioneer groups mainly test the safety of three doses. At present, the cases of the three groups have been accepted and entered the three-month medication stage . The data is expected to be released in late June at the earliest.